|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,495 GBX | -0.20% |
|
-1.32% | +2.74% |
July 16 (Reuters) - GSK plc:
* NATIONAL ADVISORY COMMITTEE ON IMMUNIZATION (NACI) RECOMMENDS RSV VACCINES, INCLUDING AREXVY, FOR OLDER ADULT POPULATIONS
* GSK: RSV VACCINATION RECOMMENDED FOR CONSIDERATION BY ADULTS AGED 60 TO 74 YEARS OF AGE IN CONSULTATION WITH THEIR HEALTH CARE PROVIDER Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)
| 1st Jan change | Capi. | |
|---|---|---|
| +2.74% | 79.32B | |
| +63.32% | 856B | |
| +39.28% | 631B | |
| -4.54% | 359B | |
| +17.62% | 325B | |
| +8.17% | 297B | |
| +5.60% | 234B | |
| +16.32% | 226B | |
| +14.69% | 177B | |
| +2.08% | 165B |
GSK PLC 
